Plain-English translation of NCT05579392 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Researchers at Rush University Medical Center are testing whether bright light therapy — delivered through wearable glasses called Re-Timer glasses — can help reduce intestinal inflammation and improve quality of life in people with inflammatory bowel disease (Crohn's disease or ulcerative colitis). The study focuses on how this treatment might strengthen your gut barrier and reduce harmful inflammation markers in your blood and stool. You would wear the glasses for one hour each morning for four weeks.
Sleep problems are common in inflammatory bowel disease and can trigger disease flares and hospitalizations. Recent research suggests that sleep disruption is a modifiable risk factor—meaning it might be something doctors can help improve. This trial explores whether bright light therapy could improve sleep quality and reduce intestinal inflammation, offering a simple, non-medication option to help prevent flares and improve daily life.
You likely qualify if…
You likely don't qualify if…
First, you'll visit the clinic for screening tests including blood work and a stool sample to check for inflammation. If you qualify, you'll wear a watch-like activity tracker for 21 days to measure your sleep patterns, and complete questionnaires about your sleep, diet, and quality of life. Then you'll be randomly assigned to wear either the active bright light glasses or placebo glasses for 60 minutes every morning for four weeks. Before and after this four-week period, you'll provide blood and urine samples so researchers can measure changes in inflammation markers.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States